Denmark's Smoking Rate and E-cigarette Use Rise with Flavor Ban

Feb.15.2023
Denmark's Smoking Rate and E-cigarette Use Rise with Flavor Ban
Danish smoking and e-cigarette use increased from 2020 to 2022, despite a flavor ban in 2022, according to a report.

According to the latest data released by the Danish National Health Committee in February 2023, smoking and e-cigarette use have both increased in Denmark from 2020 to 2022. It is reported that a flavor ban in Denmark officially took effect on April 1, 2022.


A report has revealed the smoking rate in Denmark from 2020 to 2022.


The percentage of smokers has increased from 18% to 19%.


The percentage of smokers aged 15-29 years has increased from 23% to 25%.


The usage rate of electronic cigarettes has increased from 3% to 5%.


The usage rate of electronic cigarettes among individuals aged 15-29 is between 4% and 7%.


In the years 2020-2022, there was a significant increase in the number of fruit and candy/soft drink flavored electronic cigarettes.


The percentage of users of fruit-flavored electronic cigarettes has increased from 47% to 67%.


The percentage of candy and soft drink flavor users has increased from 21% to 32%.


The percentage of fruit-flavored e-cigarette users aged 15-29 increased from 67% to 83%.


The percentage of candy/soft drink flavor users aged 15-29 has increased from 32% to 41%.


However, the increase in Denmark's smoking rate failed to lead to an increase in the rate of quitting smoking. From 2020 to 2022, the number of e-cigarette users who completely quit smoking decreased from 41% to 38%. This indicates that the ban on electronic cigarettes may decrease their effectiveness as a smoking cessation tool.


Officials from a Danish health research institution have stated that even though Denmark has implemented a flavor ban, illegal e-cigarettes are still circulating through black markets and being sold to children and young people through social media. The Danish authorities do not have enough resources to handle the growing illegal market.


This document has been generated through artificial intelligence translation and is provided solely for the purposes of industry discourse and learning. Please note that the intellectual property rights of the content belong to the original media source or author. Owing to certain limitations in the translation process, there may be discrepancies between the translated text and the original content. We recommend referring to the original source for complete accuracy. In case of any inaccuracies, we invite you to reach out to us with corrections. If you believe any content has infringed upon your rights, please contact us immediately for its removal.

Special Report|FDA Revises Device Name in Glas Vape Authorization; Company Signals Optimism on Menthol, Flavored Pods
Special Report|FDA Revises Device Name in Glas Vape Authorization; Company Signals Optimism on Menthol, Flavored Pods
The FDA updated public records on the PMTA authorization of a Glas vape product, renaming “Glas G Device” to “Glas G² Device” and releasing the order letter detailing scientific review and marketing restrictions. Company disclosures suggest the platform may include age-verification technology. If confirmed, Glas G² could be the first vape with device-level age verification to receive an FDA MGO. Glas executives also said menthol and other flavored pods could gain authorization in the future.
Special Report
Mar.14
Israel’s Finance Ministry Advances New Tax Plan for Vapes, Tobacco Pouches and Nicotine Pouches
Israel’s Finance Ministry Advances New Tax Plan for Vapes, Tobacco Pouches and Nicotine Pouches
Israel’s Finance Ministry is advancing a new bill to tax e-cigarettes, tobacco pouches and nicotine pouches. According to the report, once approved by the Knesset Finance Committee, the initiative would only require the signature of Finance Minister Bezalel Smotrich to take effect. The plan would lower the tax on vape liquid while introducing new taxes on vape devices and on tobacco and nicotine pouches.
Apr.22 by 2FIRSTS.ai
French Anti-Tobacco Group Contre-Feu Calls for Plain Packaging Across All Vaping Products
French Anti-Tobacco Group Contre-Feu Calls for Plain Packaging Across All Vaping Products
French anti-tobacco group Contre-Feu said in a statement released on April 14 that e-cigarette manufacturers are encouraging nicotine dependence among young people through targeted marketing and called for concrete measures to protect minors. The group asked for plain packaging for all vaping products, strict regulation of flavor names, and a ban on online sales.
Apr.15 by 2FIRSTS.ai
Japan Tobacco Releases Three Ploom AURA Collaboration Panels Inspired by “Sake”
Japan Tobacco Releases Three Ploom AURA Collaboration Panels Inspired by “Sake”
Japan Tobacco announced that it will sponsor “CRAFT SAKE WEEK 2026,” to be held at Roppongi Hills Arena, and set up a dedicated smoking area called “Ploom LOUNGE.” Three Ploom AURA collaboration front panels inspired by the theme of “sake” will be offered at the venue, along with trial use, sales, and related original content.
Apr.13 by 2FIRSTS.ai
UKVIA Says VApril 2026 Will Highlight Consumer Impact of Tobacco and Vapes Bill
UKVIA Says VApril 2026 Will Highlight Consumer Impact of Tobacco and Vapes Bill
The UK Vaping Industry Association said it will launch the ninth annual VApril campaign next month. The association described VApril as the world’s largest vape awareness initiative and said it has for almost a decade supported adult smokers looking to quit through vaping by providing evidence-based information, expert insights and practical guidance
Mar.24 by 2FIRSTS.ai
Acting CTP Director Says FDA Cut Premarket Tobacco Application Backlog by About 70% Over the Past Year
Acting CTP Director Says FDA Cut Premarket Tobacco Application Backlog by About 70% Over the Past Year
FDA Center for Tobacco Products Acting Director Bret Koplow said at the American Tobacco and Nicotine Forum that the agency has reduced its premarket tobacco application backlog by about 70% over the past year and eliminated the acceptance queue. He said FDA has reviewed about 27 million applications, but only a small number have been authorized, mainly because most submissions lacked the scientific data needed to demonstrate public health benefits.
Apr.23 by 2FIRSTS.ai